Medical News

RSS

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.

16 Sep 2009

FindPharma.com website for pharma professionals

Advanstar Communications announced today that it has launched FindPharma.com, a digital vertical search destination that will enable pharma professionals to find and filter relevant industry information, high quality suppliers and career assistance.

16 Sep 2009

FDA provides Orphan-Drug designation for Keryx' KRX-0401 to treat multiple myeloma

Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.

16 Sep 2009

Keryx Biopharmaceuticals receives orphan-drug designation for a multiple myeloma drug

AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.

16 Sep 2009

Researchers study the impact of obesity on body muscles

Experts at The University of Nottingham are working on ground-breaking research to determine, for the first time, precisely what damage obesity can inflict on the muscles in our body.

16 Sep 2009

Baucus Bill garners no Republican support

Sen. Max Baucus is unveiling his health overhaul bill today at noon and news outlets noted it will not have any Republican support.

16 Sep 2009

Teva announces availability of its Plan B One-Step emergency contraceptive over-the-counter

Teva Women’s Health, Inc. announced today that its Plan B® One-Step (levonorgestrel) tablet, 1.5 mg emergency contraceptive is now available at licensed U.S. retail pharmacies. Approved by the U.S. Food and Drug Administration (FDA) on July 10, Plan B® One-Step can help prevent an unintended pregnancy after unprotected sex or contraceptive failure with just one pill in one dose.

16 Sep 2009

Poniard Pharmaceuticals to present its corporate overview

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

16 Sep 2009

Matrix Laboratories receives tentative FDA approval for its NDA

Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.

16 Sep 2009

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

i365, Inc., A Seagate Company (NASDAQ: STX), today announced that Medical Business Service, Inc. has moved to i365’s EVault Plug-n-Protect appliance for its complete data protection and recovery capabilities. Headquartered in Coral Gables, Florida, and the largest privately owned patient billing services company for hospital-based physicians, MBS required a reliable, efficient data protection solution that would allow it to back up critical patient and business data across the company’s thirteen branches.

16 Sep 2009

KemPharm announces nomination of its second pipeline candidate

KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.

16 Sep 2009

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Phytel, the industry leader in automated, physician-led health improvement, announced today that the Mankato Clinic, one of the largest physician-owned multispecialty groups in Minnesota, has agreed to deploy its Proactive Patient Outreach solution. The nearly century-old Mankato Clinic, which includes 110 providers in nine locations, selected Phytel to help reduce its no-show rate and to increase the provision of needed services to its patients.

16 Sep 2009

Children's Hospital enrolls patients for ExCell clinical study

Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling patients for the ExCell study. Children's Hospital is the 24th in a series of cord blood transplant sites worldwide, five of which are children's centers, participating in the study in the U.S., Spain, Italy, Hungary and Israel.

16 Sep 2009

PCEC to provide free prostate cancer screenings

This September, the Prostate Conditions Education Council reminds men to set aside 10 minutes to take lifesaving measures. In just 10 minutes, the same amount of time it takes to shave their faces, men can be screened for prostate cancer, the second leading cause of death among American men. For one week this month the Prostate Conditions Education Council (PCEC) will be coordinating Prostate Cancer Awareness Week (PCAW), which provides free or low-cost screenings to thousands of men across the United States.

16 Sep 2009

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

16 Sep 2009

ESHRE's first workshop on male infertility

ESHRE invites you to attend its first workshop on male infertility in Thessaloniki, Greece "Reproductive andrology: linking laboratory to clinical practice". The workshop provides a forum for clinicians and scientists to share research results and discuss new developments.

16 Sep 2009

UJI's current research study on early detection of Alzheimer's Disease using fMRI

The Universitat Jaume I (UJI) of Castelló is working on the early detection of Alzheimer's Disease by using functional magnetic resonance imaging (fMRI) techniques. The study is being carried out within the framework of a national project called MIND, which approaches Alzheimer's disease from a multidisciplinary perspective and involves twelve biomedicine companies and the corresponding public research organisations associated with them.

16 Sep 2009

Applied Biosystems launches MeltDoctor High-Resolution Melt Reagents for scanning DNA

Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of genomic analysis tools that will help researchers in studies that associate genetic variation with specific diseases. These new tools, known as the MeltDoctor™ High-Resolution Melt (HRM) Reagents, are for research use only and are part of a PCR-based workflow that enables researchers to cost-effectively scan DNA from a variety of biological sample types to detect the smallest genetic variations among samples.

16 Sep 2009

Role of society and business in advancing global efforts to fight climate change

Heads of state, United Nations agency heads and CEOs of the world’s top businesses will gather in New York on Tuesday, September 22, at the United Nations Summit on Climate Change to explore the role business and society can play in advancing global efforts to fight climate change.

16 Sep 2009

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and produced by MIT’s Technology Review magazine. The conference will take place September 22nd - 24th on the MIT campus in Cambridge, MA.

16 Sep 2009

Medical News

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

FindPharma.com website for pharma professionals

FDA provides Orphan-Drug designation for Keryx' KRX-0401 to treat multiple myeloma

Keryx Biopharmaceuticals receives orphan-drug designation for a multiple myeloma drug

Researchers study the impact of obesity on body muscles

Baucus Bill garners no Republican support

Teva announces availability of its Plan B One-Step emergency contraceptive over-the-counter

Poniard Pharmaceuticals to present its corporate overview

Matrix Laboratories receives tentative FDA approval for its NDA

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

KemPharm announces nomination of its second pipeline candidate

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Children's Hospital enrolls patients for ExCell clinical study

PCEC to provide free prostate cancer screenings

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

ESHRE's first workshop on male infertility

UJI's current research study on early detection of Alzheimer's Disease using fMRI

Applied Biosystems launches MeltDoctor High-Resolution Melt Reagents for scanning DNA

Role of society and business in advancing global efforts to fight climate change

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News